GH Research (GHRS) Liabilities and Shareholders Equity (2021 - 2026)

GH Research's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $288.2 million for Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity rose 53.09% year-over-year to $288.2 million; the TTM figure through Dec 2025 stood at $1.2 billion (up 50.67% YoY), while the FY2025 annual figure was $288.2 million, up 53.09% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $288.2 million, down from $302.0 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $320.5 million in Q1 2025, with the low at $188.3 million in Q4 2024.
• The 5-year median for Liabilities and Shareholders Equity is $257.2 million (2022), against an average of $256.3 million.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity declined 16.8% in 2024, then surged 53.09% in 2025.
• GH Research's Liabilities and Shareholders Equity stood at $288.1 million in 2021, then decreased by 11.71% to $254.4 million in 2022, then dropped by 11.03% to $226.3 million in 2023, then dropped by 16.8% to $188.3 million in 2024, then soared by 53.09% to $288.2 million in 2025.
• Business Quant data shows GHRS's Liabilities and Shareholders Equity at $288.2 million in Q4 2025, $302.0 million in Q3 2025, and $313.4 million in Q2 2025.